ASTRO Meeting
AI tool predicts prostate cancer recurrence after radiation
Von KI berichtet
Researchers unveiled an AI model at the ASTRO Annual Meeting that accurately predicts biochemical recurrence in prostate cancer patients following radiation therapy. The tool uses pre-treatment MRI scans and clinical data to outperform traditional risk models. This advancement could help tailor treatments more effectively.